Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment (Q74534637)
Jump to navigation
Jump to search
scientific article published on 01 September 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment |
scientific article published on 01 September 2001 |
Statements
Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment (English)
V Kunzmann
T Ruediger
M Hallek
H K Mueller-Hermelink
1 September 2001